Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SERTRALINE | 25MG | CAPSULE | Resolved | 2023-07-17 | 2023-09-06 | 198792 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216264 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2021-03-17 | 2021-07-18 | 135812 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2023-07-18 | 2023-10-17 | 198926 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211074 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-01-30 | 2024-05-17 | 217783 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2021-03-17 | 2021-07-18 | 135808 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211071 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216254 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-02-13 | 216259 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-02-26 | 2024-05-02 | 220633 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-25 | 2024-04-23 | 223214 |
| CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-20 | 2020-10-30 | 126740 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-15 | 2019-02-13 | 72253 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-13 | 2019-11-14 | 93859 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2023-10-01 | 200434 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-04-22 | 2024-05-17 | 225878 |
| VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-12-20 | 2020-02-06 | 101823 |
| VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-03-24 | 2020-04-21 | 109287 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-11-21 | 2019-02-13 | 67303 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |